Medicines Australia’s Continuing Education Program (CEP) is designed to educate medical representatives to a recognised industry standard. Dr Tristan Ling, CEP Academic Lead and Project Manager at the College of Health and Medicine, University of Tasmania talks about the 900 students that come through the program each year.
The CEP is primarily directed at medical representatives working within the prescription medicines industry, but is also recommended to people who may not be currently employed within the industry but would like to pursue a career as a medical representative. It is also available to personnel working for organisations interacting with the pharmaceutical industry.
Medicines Australia CEO Elizabeth de Somer talks about how the CEP program provides the information needed by medical representatives, that talk to health care professionals, talk with accuracy, balance and in an evidence based manner about their products.
Australian Health Journal spoke with recent CEP graduates Samantha Wicks, Christopher Lems and Megan-Anne Jefferys on their experiences in the program and how it positively impacted their confidence and knowledge of the industry.
The CEP is currently offered online through the University of Tasmania’s Unit for Medication Outcomes Research and Education (UMORE), which is housed in the University’s Pharmacy Division.
You Might also like
-
Prioritising Oral Health in Aged Care and Disability Support
Leonie Short is a Dental Practitioner and Dental Therapist. She started working as a dental therapist in Rural NSW and then moved into being an academic and researcher. Through her career, Leonie has worked at 6 universities across New South Wales and Queensland, and remaining community focused.
Leonie’s mission is to have improved oral health experiences and outcomes, however she recognises, the health system really needs to work hard to make it happen and for people to understand why it needs to be a priority.
-
Value of MedTech Report brings Industry and Government together
In June 2023 the Medical Technology Association of Australia (MTAA) launched The Value of MedTech Report – a major study quantifying the difference the MedTech industry makes to the lives of Australian patients, the healthcare system and the Australian economy.
Australian Health Journal spoke with MTAA CEO, Ian Burgess and MTAA Policy Manager, Pravin Siriwardena about the report and its key findings.
-
Australasian College of Paramedicine makes case for multi-disciplinary care
Despite being seen primarily as emergency responders, paramedics have long been providing care in the primary care space. As such, their increased involvement in primary and urgent care is a natural progression that can lead to improved health outcomes for communities. Urgent care clinics, which treat non-life-threatening injuries and illnesses, have been a recent introduction. However, when these clinics were initially proposed, paramedics were left out of the opportunity, despite being experts in urgent, acute, unplanned, and unscheduled care. They work in these types of situations every day in the ambulance service and should be utilised in these clinics to improve patient outcomes. Working as part of multidisciplinary teams with doctors and nurses can further enhance the outcomes for local communities.